Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma-Reference-Cited by-同舟云学术

Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma

Published:2021-03-28 Issue:3 Volume:39 Page:349-357
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Takakuwa Teruhito¹²^ORCID,Ohta Kensuke¹³,Nakatani Eiji⁴,Ito Tomoki⁵,Kaneko Hitomi⁶,Fuchida Shin‐Ichi⁷,Shimura Yuji⁸,Yagi Hideo⁹,Shibayama Hirohiko¹⁰,Kanda Junya¹¹,Uchiyama Hitoji¹²,Kosugi Satoru¹³,Tanaka Hirokazu¹⁴,Kawata Eri¹⁵,Uoshima Nobuhiko¹⁵,Ishikawa Jun¹⁶,Shibano Masaru¹⁷,Karasuno Takahiro¹⁸,Shindo Maki¹¹,Shimizu Yoshifumi¹⁹,Imada Kazunori⁶,Kanakura Yuzuru¹⁰,Kuroda Junya⁸^ORCID,Hino Masayuki²,Nomura Shosaku⁵,Takaori‐Kondo Akifumi¹¹,Shimazaki Chihiro⁷,Matsumura Itaru¹⁴

Affiliation:

1. Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan

2. Department of Hematology Osaka City University Graduate School of Medicine Osaka Japan

3. Hematology Ohta Clinic, Shinsaibashi Osaka Japan

4. Division of Statistical Analysis Research Support Center Shizuoka General Hospital Shizuoka Japan

5. Division of hematology First Department of Internal Medicine Kansai Medical University Medical Center Moriguchi Japan

6. Department of Hematology Japanese Red Cross Osaka Hospital Osaka Japan

7. Department of Hematology Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center Kyoto Japan

8. Division of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan

9. Department of Hematology and Oncology Nara Prefecture General Medical Center Nara Japan

10. Department of Hematology and Oncology Osaka University Graduate School of Medicine Osaka Japan

11. Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan

12. Department of Hematology Japanese Red Cross Kyoto Daiichi Hospital Kyoto Japan

13. Department of Internal Medicine (Hematology) Toyonaka Municipal Hospital Toyonaka Japan

14. Department of Hematology and Rheumatology Faculty of Medicine Kindai University Higashi‐osaka Japan

15. Department of Hematology Japanese Red Cross Kyoto Daini Hospital Kyoto Japan

16. Department of Hematology Osaka International Cancer Institute Osaka Japan

17. Department of Hematology Sakai City Medical Center Sakai Japan

18. Department of Hematology Rinku General Medical Center Izumisano Japan

19. Department of Hematology Takarazuka Municipal Hospital Takarazuka Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2863

Reference27 articles.

1. International Staging System for Multiple Myeloma

2. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

3. Revised International Staging System Applied to Real World Multiple Myeloma Patients

4. Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma

5. Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ixazomib‐based maintenance therapy after bortezomib‐based induction in patients with multiple myeloma not undergoing transplantation: A real‐world study;Cancer Medicine;2021-10-16